North America minimally invasive surgical instruments market is expected to reach USD 7.1 billion by 2023 from USD 4.64 billion in 2018, growing at a CAGR of 8.90% for the next five years 2018-2023.
Minimally invasive surgical procedures involve the use of surgery instruments (such as arthroscopic or laparoscopic devices) and remote controlled instruments to monitor the surgery through large display panel or endoscopy. Minimally invasive procedures eliminate large incisions & infections, reduce the long time hospital admission, and promote the early recovery. Currently, the utilization of minimally invasive surgical instruments has been increased. Some of the minimally invasive surgical instruments include, visualizing scope, stents, sutures, dilators, electrosurgical instruments, balloon inflation devices, guiding catheters, trocars, rasps, and cannulas, among others.
Increasing aging population, growing number of surgical procedures, rising government investments, high prevalence rate of lifestyle disorders, and increasing incidence of bone disorders (such as osteoporosis arthritis) & spine injuries are driving the growth of minimally invasive surgical instruments market in North America. However, stringent regulatory policies for the approval advanced surgery instruments and irregular reimbursement scenarios in this region are expected to restrain the growth of minimally invasive surgical instruments market in North America.
North America minimally invasive surgical instruments market is segmented based on the product, application, and end users. Based on product, the market is further sub-segmented as handheld instruments, electrosurgical devices, inflation systems, guiding devices, cutter instruments, and auxiliary instruments. Handheld instruments segment is estimated to command the largest share of North America minimally invasive surgical instruments market by product in 2018. The electrosurgical devices segment is expected to grow at the highest CAGR during the forecast period 2018-2023.
Application segment is further categorized as orthopedic, gastrointestinal, cardiothoracic, urological, cosmetic, gynecology, vascular, and other applications. The orthopedic segment is estimated to command the largest share of North America minimally invasive surgical instruments market by application in 2018. Based on end users, the market is segmented as private hospitals & surgical clinics, government hospitals and academic & research institutes. The private hospitals & surgical clinics segment is estimated to account for the largest share of North America minimally invasive surgical instruments market by end users in 2018.
On the basis of geographical areas, North America minimally invasive surgical instruments market is segmented as U.S., and Canada. U.S., is estimated to account for larger share of the North America minimally invasive surgical instruments market in 2018, whereas Canada is estimated to grow at a higher CAGR during the forecast period 2018-2023.
The key players in minimally invasive surgical instruments market such as, Medtronic plc (Ireland), Ethicon, Inc. (U.S.), Aesculap, Inc. (Germany), Stryker Corporation (U.S.), Smith & Nephew (U.K.), ConMed Corporation (U.S.), Abbott Laboratories (U.S.), Applied Biomedical Resources Corporation (U.S.), Microline Surgical (Japan), and Zimmer Biomet (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Handheld Instruments
5.1.2.1 Introduction
5.1.2.2 Stents
5.1.2.3 Visualizing Scopes
5.1.2.4 Graspers
5.1.2.5 Retractors/Elevators
5.1.2.6 Sutures
5.1.2.7 Dilators
5.1.2.8 Forceps and Spatulas
5.1.2.9 Other Handheld Instruments
5.1.3 Electrosurgical Devices
5.1.3.1 Introduction
5.1.3.2 Electrosurgical Generators
5.1.3.3 Electrosurgical Instruments
5.1.3.4 Electrocautery Devices
5.1.4 Inflation Systems
5.1.4.1 Introduction
5.1.4.2 Balloons
5.1.4.3 Balloon Inflation Devices
5.1.4.4 Other Inflation Systems
5.1.5 Guiding Devices
5.1.5.1 Introduction
5.1.5.2 Guiding Catheters
5.1.5.3 Guidewires
5.1.6 Cutter Instruments
5.1.6.1 Introduction
5.1.6.2 Trocars
5.1.6.3 Rasps
5.1.6.4 Other Cutter Instruments
5.1.7 Auxiliary Instruments
5.1.7.1 Introduction
5.1.7.2 Cannulas
5.1.7.3 Staplers
5.1.7.4 Clamps
5.1.7.5 Closures
5.2 Application
5.2.1 Introduction
5.2.2 Orthopedic Surgery
5.2.3 Gastrointestinal Surgery
5.2.4 Cardiothoracic Surgery
5.2.5 Urological Surgery
5.2.6 Cosmetic/Bariatric Surgery
5.2.7 Gynecological Surgery
5.2.8 Vascular Surgery
5.2.9 Other Applications
5.3 End Users
5.3.1 Introduction
5.3.2 Private Hospitals and Surgical Clinics
5.3.3 Government Hospitals
5.3.4 Academic and Research Institutes
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic plc (Ireland)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Ethicon, Inc. (U.S.)
8.3 Aesculap, Inc. (Germany)
8.4 Stryker Corporation (U.S.)
8.5 Smith & Nephew (U.K.)
8.6 ConMed Corporation (U.S.)
8.7 Abbott Laboratories (U.S.)
8.8 Applied Biomedical Resources Corporation (U.S.)
8.9 Microline Surgical (Japan)
8.10 Zimmer Biomet (U.S.)
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
